Activation of Cell Surface Bound 20S Proteasome Inhibits Vascular Cell Growth and Arteriogenesis
(a) CTA 157-2 specifically activates 20S proteasome and (b) control IgM antibody is without effect. (c) Proteasome inhibitor lactacystin reduces proteasome activity as expected. (d) Activation of the proteasome is purified membrane preparations with CTA 157-2 treatment.
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.